Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010–2016

Published:2018-07 Issue:31 Volume:36 Page:4701-4707
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Demczuk Walter H.B.,Martin Irene,Desai Shalini,Griffith Averil,Caron-Poulin Laurence,Lefebvre Brigitte,McGeer Allison,Tyrrell Gregory J.,Zhanel George G.,Gubbay Jonathan,Hoang Linda,Levett Paul N.,Van Caeseele Paul,Raafat Gad Rita,Haldane David,Zahariadis George,German Gregory,Daley Bernier Jennifer,Strudwick Lori,Mulvey Michael R.

Funder

University of Manitoba

Pfizer

Wyeth

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference67 articles.

1. 23-valent pneumococcal polysaccaride vaccine WHO position paper;WHO Publication;Wkly Epidemiol Rec,2008

2. Pneumococcal capsules and their types: past, present, and future;Geno;Clin Microbiol Rev,2015

3. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine;Pilishvili;J Infect Dis,2010